Groundbreaking Data from ROADS Trial Endorses GammaTile as New Standard for Brain Metastases Treatment#USA#Tempe#ASCO#GammaTile#ROADS_Trial
Groundbreaking Data from ROADS Trial Endorses GammaTile as New Standard for Brain Metastases Treatment
Recent publication highlights the remarkable findings of the ROADS Phase 3 trial, solidifying GammaTile® as a new standard-of-care for operable brain metastases.
third-news.com
September 29, 2026 at 12:24 PM
Groundbreaking Data from ROADS Trial Endorses GammaTile as New Standard for Brain Metastases Treatment#USA#Tempe#ASCO#GammaTile#ROADS_Trial